Effect of LASER therapy Vs conventional techniques on clinical and radiographic outcomes of deciduous molar pulpotomy : a systematic review and meta-analysis by Chandran, Vennila et al.
J Clin Exp Dent. 2020;12(6):e588-96.                                                                                                                                                              LASER Vs Conventional pulpotomy for primary molars
e588
Journal section: Community and Preventive Dentistry                      
Publication Types: Review
Effect of LASER therapy Vs conventional techniques 
on clinical and radiographic outcomes of deciduous 
molar pulpotomy: A systematic review and meta-analysis
Vennila Chandran 1, Venkitachalam Ramanarayanan 2, Medhini Menon 1, R Balagopal Varma 1, Vinita Sanjeevan 3
1 Department of Pedodontics and Preventive Dentistry, Amrita School of Dentistry, Amrita Vishwa Vidyapeetham, Kochi, Kerala, 
India
2 Department of Public Health Dentistry, Amrita School of Dentistry, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
3 Department of Public Health Dentistry, Goa Dental College, Bambolim, Goa, India
Correspondence:
Department of Public Health Dentistry
Amrita School of Dentistry
AIMS, Amrita Vishwa Vidyapeetham





Background: To systematically review the effectiveness primary molar pulpotomy based on the clinical and radio-
graphic outcomes using lasers over the conventional therapies.
Material and Methods: This systematic review and meta-analysis included Randomized or Quasi-randomized trials 
comparing LASER with conventional pulpotomy therapies (formocresol, ferric sulphate, MTA or calcium hy-
droxide) with atleast 6-month follow-up period was included. Risk of bias of included studies was assessed and 
metanalysis was done using RevMan software.
Results: Of the 1383 articles that were searched, only 14 studies were included for qualitative synthesis and 10 for 
meta- analysis. There was no statistically significant difference in clinical success rate [OR 0.99, 95%CI (0.19,5.22)] 
or radiographic success rate [OR 0.77, 95%CI (0.31,1.87)] of LASER therapy compared to Formocresol in primary 
molar pulpotomy for 6 months. No statistically significant difference were found in clinical success rate [OR 1.04, 
95%CI (0.35,3.07)] and radiographic success rate [OR 0.71, 95%CI (0.37,1.35)] at 12 month follow-up also. Com-
parison of LASER with Ferric Sulphate also did not show a statistically significant difference.
Conclusions: Meta-analysis showed no statistically significant difference in clinical and radiographic outcomes of 
LASER pulpotomy with conventional pulpotomy (formocresol and ferric sulphate) at 6 and 12 months follow-up. 
However, there was considerable risk of bias in the included studies.
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Introduction
Dental pulp can be defined as a connective tissue of 
mesodermal origin, which is highly vascularized and 
innervated structure enclosed by dentin with communi-
cations to the periodontal ligament. The pulp present in 
the crown and root are called coronal pulp and radicu-
lar pulp respectively. A vital pulp is essential to good 
dentition. The preservation of a vital pulp during opera-
tive procedures and successful management in case of 
disease are  the most important challenges to the clinical 
dentist. Vital pulp therapy plays a major role in the pre-
servation of primary dentition after caries affliction (1).
Currently, there are three vital pulp therapy (VPT) op-
tions for treatment of deep dentin caries lesions approxi-
mating the pulp in vital primary teeth viz.  indirect pulp 
cap, direct pulp cap (DPC) and pulpotomy (2). The pulp 
is an organ with remarkable reparative abilities (3). Pul-
potomy is the most preferred pulp therapy when only the 
coronal pulp is inflamed due to bacterial penetration fo-
llowing carious, traumatic or iatrogenic causes, and the 
radicular pulp is free from inflammation (4). and it still 
continues to be the most prevalent vital pulp therapy.
According to Finn (1995), pulpotomy is defined as the 
complete removal of the coronal portion of the den-
tal pulp, followed by placement of a suitable dressing 
or medicament that will promote healing and protects 
vitality of the pulp. The remaining vital radicular pul-
pal tissue were treated with different pulpotomy medi-
caments through three different mechanisms viz. de-
vitalization (such as formocresol, electrosurgery, and 
LASERtherapy), preservation (such as ferric sulfate 
and glutaraldehyde) and regeneration (such as MTA, 
calcium hydroxide) (5).
Since 1950, formocresol (FC) has been the widely used 
material for pulpotomy of primary molars (6). A suc-
cessful pulpotomy depends on various important fac-
tors like case selection, clinical diagnosis, intraopera-
tive diagnosis and most importantly the material used 
for the pulpotomy procedure. Formocresol pulpotomy 
(FC)  is still a popular pulp therapy despite the con-
cerns raised due to its toxicity, mutagenicity and car-
cinogenicity  due to a good clinical and radiographic 
success rates (7).
Ferric Sulfate (FS) a non-aldehyde chemical has gained 
attention recently as a pulpotomy agent. This haemosta-
tic agent was proposed on the theory that it prevents the 
problem in clot formation thereby reducing the chances 
of inflammation and internal resorption (7).
Mineral Trioxide Aggregate (MTA) is a newer material 
used for pulpotomies with a high rate of success. Clini-
cal trials supported that MTA performs equal to or better 
than formocresol or ferric sulfate and may be the most 
desirable pulpotomy agent in the future (8).
The electrosurgical pulpotomy(ES) and the LASER pul-
potomy, are the forms of non chemical devitalization 
that emerged during the last decade. The electrocautery 
carbonizes and denatures the pulp and prevents bacterial 
contamination (9).
A recently emerged non pharmacotherapeutic method, 
was the use of LASER, in which the LASER energy is 
able to overcome the histologic deficits of electrosur-
gery by accelerating the wound healing of the pulp and 
also the expression of the lectins and collagen levels. 
The advantage of LASER has also been suggested as an 
alternative, owing to its hemostatic, antimicrobial, and 
cell-stimulating properties with minimal alteration to the 
pulpal tissue (10). It is therefore considered as a com-
plementary step to the pulpotomy process in primary 
teeth (11). One of the benefits of using LASER in pe-
diatric dentistry is its ability for selective and precise in-
teraction with diseased tissues. Only a minimal thermal 
necrosis of adjacent tissues is produced with LASERS 
than with electrosurgical instruments (12).
Based on the review of literature it has been found that 
the primary teeth can be treated with many different te-
chniques and medicaments, but the success rates of the-
se newer pulpotomy medicaments are still uncertain due 
to the varying results about the clinical, radiographical 
and histopathological outcomes.
Hence the objective/PICO statement of this study is to 
perform a systematic review and meta-analyses, to eva-
luate the effectiveness primary molar pulpotomy (Popu-
lation) based on the clinical and radiographic outcomes 
(Outcomes) using LASERS (Intervention) over the con-
ventional therapy, amongst the pulpotomy medicaments 




The protocol of the study was registered with Prospero 
(International Prospective Register of Systematic Re-
views) with Register no: CRD42018093035. 
-Eligibility criteria
Randomized or Quasi-randomized trials comparing two 
or more pulpotomy techniques of which one was LA-
SER and the other was any of the conventional therapies 
(formocresol, ferric sulphate, MTA or calcium hydroxi-
de) with atleast 6-month follow-up period was included. 
-Types of participants
Children (4 to 10 years of age) undergoing pulpotomy 
therapy in vital primary molars with carious pulp ex-
posure using LASER treatment and formocresol and/or 
ferric sulphate and/or mineral trioxide aggregate and/or 
calcium hydroxide were the study participants. Children 
with any systemic disorders or pulpotomy conducted on 
teeth other than primary molars were excluded from the 
study.
Intervention group consisted LASER therapy for pri-
mary molar pulpotomy and comparator groups were 
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Conventional techniques for primary molar pulpotomy 
(formocresol, ferric sulphate, MTA and biodentine).
-Information sources and search
The literature search was done with the electronic da-
tabases viz. The Cochrane Oral Health’s Trials Regis-
ter; The Cochrane Central Register of Controlled Trials 
(CENTRAL) (The Cochrane Library); MEDLINE Ovid 
(from 1946 onwards); Google Scholar; ProQuest and 
EBSCO. Search was also done based on references of 
included studies and hand searching was also attempted.
No limitations were imposed on the date and country of 
the publication, but only trials published in the English 
language were included in the review. The search stra-
tegies for databases were modelled on that designed for 
MEDLINE Ovid.
Key words used to identify relevant studies were (“LA-
SERS” AND (“MTA” OR “formocresol” OR “ferric 
sulphate” OR “biodentine”) AND “pulpotomy”); (“LA-
SERS” AND “MTA” AND “pulpotomy”); (“LASERS” 
AND “formocresol” AND “pulpotomy”); (LASER) 
AND pulpotomy; (“LASERS” AND “ferric sulphate” 
AND “pulpotomy”); (“LASERS” AND “biodentine” 
AND “pulpotomy”).
-Study selection
The screening of titles and the abstracts of potentially re-
levant articles was performed by VC and RV before retrie-
ving full articles. The risk of bias using the recommenda-
tions in the Cochrane Handbook for Systematic Reviews 
of Interventions has been individually assessed by VC and 
RV independently. The disagreements if any, were to be re-
solved by discussion or, if necessary, by consulting a third 
review author (MM) in order to reach a consensus.
-Data items
A data extraction form was prepared in Microsoft Excel 
by RV. Both the authors (VC and RV) agreed on the de-
sign of the data extraction form. In every included trial, 
characteristics of the participants, details of the interven-
tions applied and outcomes were entered. VC and RV 
independently extracted the data and were not blinded to 
the authors of the included studies.
-Outcome measures
Primary outcome measures were assessment of clinical 
and radiographic success separately after 6 months and 
12 months of procedure. 
-Assessment of risk of bias
We evaluated all the studies, which were included for 
analysis, by the recommended approach for assessing the 
risk of bias (13). All the included studies were assessed in-
dependently and in duplicate by two review authors (VC 
and RV) for study design characteristics and features of 
internal validity. Assessment was done within and across 
studies. We assessed for publication bias as recommended 
in Cochrane Handbook using funnel plots. 
-Summary measures
The treatment effect was summarized into dichotomous 
outcomes using odds ratio.A method of fixed-effects 
model were used to calculate a pooled estimate of effect 
and its 95% confidence intervals (CIs).
-Synthesis of results and Additional analyses
Meta-analysis was performed for methodologically si-
milar studies. We concluded the heterogeneity based on 
patient demographics, clinical circumstances, and the 
comparability of the interventions applied. We also eva-
luated of the heterogeneity of the data using Cochran’s 
Q statistic, a Chi2 test, with a threshold p value of less 
than 0.10. The consistency of the results was assessed 
visually using forest plots and by the I2 statistic (14). 
Meta-analysis could be performed only for LASER Vs 
Formocresol and LASER Vs Ferric sulphate as suffi-
cient studies were not available for other included in-
terventions (MTA, biodentine and calcium hydroxide).
Results 
About 14 studies were included for the qualitative syn-
thesis while 10 studies were included for quantitative 
synthesis (meta-analysis). The PRISMA flow diagram is 
given in Figure 1. All the included studies were Rando-
mized Controlled Trials and sample size ranged from 20 
to 200. The studies were conducted from 2005 to 2018. 
Since the follow-up times were varied across studies, it 
was decided to include 6 months and 12 months follow 
up clinical and radiographic values for this study. Study 
participants were children age 3 to 9 years and study se-
tting were mostly dental clinics. The characteristics of 
included studies are given in Table 1.
Risk of bias within studies and across studies
Table 2 and 3 show the risk of bias across the studies 
and within studies respectively. The assessment of risk 
of bias was indicating a high risk of the included studies. 
No study included in the study was free of all the biases. 
All studies except that of Joshi et al. did not blind the 
participants. Allocation concealment was also not at-
tempted in most of the studies. However, there was low 
risk of bias as far as attrition of study participants and 
selective reporting was concerned. 
Effect of interventions
-LASER pulpotomy Vs Formocresol
•Clinical and Radiographic success after 6 months
In 8 studies involving the 480 participants, we found no 
statistically significant difference in clinical success rate 
[OR 0.99, 95% CI (0.19 to 5.22)] of LASER therapy 
when compared to the conventional Formocresol thera-
py in primary molar pulpotomy (Fig. 2a). A total of 7 
studies with 383 participants assessed the radiographic 
success rate, which did not show any statistically signi-
ficant difference between the two groups [OR 0.77, 95% 
CI (0.31 to 1.87)]. There was no heterogeneity (0%) 
across studies (Fig. 2b). 
•Clinical and Radiographic success after 12 months
In 7 studies involving the 401 participants, no statistica-
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Fig. 1: Search strategy and PRISMA flow diagram.
lly significant difference were found in clinical success 
rate [OR 1.04, 95% CI (0.35 to 3.07)] of LASER the-
rapy when compared to the conventional Formocresol 
therapy in deciduous molar pulpotomy after 12 months 
(Fig. 2c). A total of 7 studies with 401 participants were 
available to assess the radiographic success rate and 
found no statistically significant difference between the 
two groups [OR 0.71, 95% CI (0.37 to 1.35)]. There was 
slight heterogeneity (<3%) across studies (Fig. 2d). 
-LASER pulpotomy Vs Ferric sulphate
•Clinical and Radiographic success after 6 months
In 4 studies involving the 290 participants, we found 
no statistically significant difference in clinical success 
rate [OR 3.96, 95% CI (0.63 to 24.94)] of LASER the-
rapy when compared to the conventional Ferric sulphate 
therapy in primary molar pulpotomy. There was no he-
terogeneity (0%) across studies (Fig. 3a). A total of 3 
studies with 190 participants assessed the radiographic 
success rate and did not show any statistically significant 
difference between the two groups [OR 1, 95% CI (0.37 
to 2.72)]. There was slight heterogeneity (10%) across 
studies (Fig. 3b). 
•Clinical and Radiographic success after 12 months
In 3 studies involving the 196 participants, no statistica-
lly significant difference were found in clinical success 
rate [OR 1.82, 95% CI (0.38 to 8.71)] of LASER thera-
py when compared to the conventional Ferric sulphate 
therapy. There was no heterogeneity (0%) across studies 
(Fig. 3c). A total of 3 studies with 196 participants were 
available to assess the radiographic success rate and 
found no statistically significant difference between the 
two groups [OR 1.49, 95% CI (0.67 to 3.32)]. There was 
moderate heterogeneity (42%) across studies (Fig. 3d).
A symmetrical funnel plot was obtained for all outcomes 
having more than 5 studies. 
Discussion
One of the ultimate goals for all pediatric dentists is to 
preserve the primary dentition in good health until it 
succumbs to normal exfoliation. These teeth are vital 
for proper mastication and speech, maintenance of arch 
length, and are crucial for the overall health of children. 
Early childhood caries is one of the major reasons for 
early pulpal involvement of primary teeth and unfortu-
nately the  prevalence of ECC estimated in a study in 
2012 has shown to be in between a range of 50%- 80% 
(15). A recent study by Anil S et al. in 2017 has shown a 
soaring prevalence of 85% in developing countries  and 
in the underprivileged population in the developed coun-
tries (16).
Taking into consideration this alarming prevalence, pul-
potomy serves as one such vital pulp therapy that comes 
into rescue to conserve these primary teeth. In pulpo-
tomy only coronal pulp is removed with a rationale that 
the radicular pulp may be healthy or is capable of self 
healing. 
Pediatric dental practitioners are still in a constant hunt 
for the most ideal medicament to be used in pulpotomy. 
Among the numerous factors that decide the success or 
failure of pulpotomy, the medicament/technique used 
forms the touchstone of pulpotomy (17).  The ideal me-
dicament for pulpotomy should possess the following 
prerequisites: non toxicity, bactericidal, biocompatible 
to pulp and surrounding structures, aid in healing of the 
remaining radicular pulp without impeding physiologic 
root resorption (18).
Formocresol has been the gold standard and has been 
in use for the last 70 years and is still extensively used 
among pedodontists due to its ease of application and 
high clinical success rates (19). Nevertheless many stu-
dies have shown cytotoxicity and mutagenecity to be its 
hazardous effects (20). Thereafter various medicaments 
like gluteraldehyde, calcium hydroxide, ferric sulfate, 
freeze dried bone and newer materials like MTA and 




Author Country Year of 
publication
Test group Control 
group
Follow 




1 Jeng Fen-Liu Taiwan 2006 LASERS Formocresol 9-66 4-7
2 Odabas et al. Turkey 2007 LASERS Formocresol 1,3.6,9,12 6-9
3 Vahid golpaegani Iran 2009 LASERS Formocresol 6,12 4-7
4 Huth Germany 2011 LASERS Formocresol 6,12,18,24,36 <8
5 Durmus et al. Turkey 2014 LASERS Formocresol, 
ferricsulphate
1,3.6,9,12 5-9
6 P.Yadav et al. India 2014 LASERS Ferricsulphate,
electrosurgery
1,3,6,9 4-7




8 Sheila.C India 2017 LASERS Formocresol 1,3,6 <8
9 Joshi et al. India 2017 LASERS Formocresol 3,6,12 4-9
10 Ansari et al. Iran 2018 LASERS Formocresol,
Ferricsulphate
6,12 3-9
Table 1: Characteristics of included studies.
Risk of bias across studies










Random sequence generation 4 (28.5%) 7 (50%) 3 (21.5%)
Allocation concealment 2 (14.2%) 0 12 (85.8%)
Blinding of participants and personnel 1 (7%) 0 13 (93%)
Blinding of outcome assessment 7 (50%) 0 7 (50%)
Incomplete outcome data 13 (93%) 1 (7%) 0
Selective reporting 14 (100%) 0 0
Other biases 14 (100%) 0 0
Table 2: Risk of bias across studies.
biodentine were introduced into pulpotomy and innume-
rable studies have been conducted comparing the suc-
cess of each of these medicaments. Recently non phar-
macological methods like electrosurgery and LASERS 
have also been used extensively for pulpotomy. 
Use of ferric sulfate has been studied widely and it is 
shown to act like a hemostatic agent during pulpotomy. 
A metalloprotein complex is formed, when ferric sulfate 
contacts with blood, and the membrane of this ferric ion 
protein seals and block vessels mechanically, producing 
hemostasis (21). This agglutinated protein plugs occludes 
the capillary orifices preventing irritating components of 
subbase to enter the radicular pulp (22). It showed enhan-
ced action in minimizing inflammation and internal reso-
prtion when compared to calcium hydroxide as it aided 
in physiologic clot formation. The material has various 
advantages like easy availability, no heat is produced, no 
electricity required and good handling properties (23). 
LASERS possess absorption effect on tissues that lead 
to cellular vaporization and ablation, that aid in proper 
hemostasis. This vaporization effect causes molecular 
bond breaking and photobiochemical disruption that cau-
ses destruction of bacteria. LASERS help in healing by 
expression of lectins and collagens (17). This systematic 
review analyzed all published clinical trials that compa-
res LASER with conventional pulpotomy medicaments 



















Ansari 2018 Unclear risk High risk High risk Low risk Low risk Low risk Low risk
Durmus 2014 Unclear risk High risk High risk Low risk Low risk Low risk Low risk
Fernandex 2015 Low risk Low risk High risk Low risk Low risk Low risk Low risk
Golpayegan 2009 Unclear risk High risk High risk Low risk Low risk Low risk Low risk
Gupta 2015 Unclear risk High risk High risk High risk Low risk Low risk Low risk
Huth 2011 Low risk Low risk High risk Low risk Unclear risk Low risk Low risk
Joshi 2017 Unclear risk High risk Low risk Low risk Low risk Low risk Low risk
Liu 2006 High risk High risk High risk High risk Low risk Low risk Low risk
Niranjani 2015 Low risk High risk High risk High risk Low risk Low risk Low risk
Odabas 2007 High risk High risk High risk High risk Low risk Low risk Low risk
Saltzman 2005 Low risk High risk High risk Low risk Low risk Low risk Low risk
Sheila 2017 High risk High risk High risk High risk Low risk Low risk Low risk
Uloopi 2016 Unclear risk High risk High risk High risk Low risk Low risk Low risk
Yadav 2014 Unclear risk High risk High risk High risk Low risk Low risk Low risk
Table 3: Risk of bias within studies.
Fig. 2: Forest plot of Laser Vs Formocresol.
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Fig. 3: Forest plot of Laser Vs Ferric sulphate.
mainly formocresol and ferric sulfate.  
LASER Versus Formocresol
The study conducted by Mesut Enes Odabas et al. (2007) 
compared the clinical, radiographic and histopathologic 
outcomes of formocresol pulpotomy and ND:YAG LA-
SER pulpotomy in 18 teeth planned for serial extraction 
with a following period of 1,3,6,9 and 12 months. This 
study was one among very few studies that has compa-
red the histopathologic findings post LASER and formo-
cresol pulpotomy. The clinical, radiographic and histo-
pathologic success rates was found to be not statistically 
significant till the 12th  month follow up, but there was 
a statistically significant difference between the 7th day 
and 60th day follow up within the LASER group, when 
considering the inflammatory cell response criteria by 
Hebling et al. There was moderate inflammatory cell 
infiltration on 7th day but had reduced to only slight in-
filtration around the exposure site (24). Sheila C et al. in 
2017 conducted a randomized, single blind split mouth 
study of 20 teeth to compare the clinical and radiogra-
phic success rates of Formocresol versus diode LASER 
pulpotomy. Both clinically and radiographically, the re-
sults were insignificant at the 6th and 12th month follow 
up (17). A study by Vahid et al. compared Low level LA-
SER therapy pulpotomy to conventional Formocresol 
pulpotomy both clinically and radiographically at 6 and 
12 months. At the end of 6th and 12th month both groups 
showed statistically insignificant results (25). According 
to Utsunomiya et al. LLLT accelerated wound healing 
and expression of lectins and collagens in study done 
on dental pulp of dogs (26).  Ferreira et al. showed that 
LLLt induces a positive effect on the reactional dentino-
genesis in human teeth (27). Another study by Ana Paula 
et al. in 2015 also assessed the effectiveness of LLLT on 
60 vital deciduous molars and compared it both  clini-
cally and radiographically with formocresol as well as 
calcium hydroxide pulpotomy. There was a fourth group 
which was included where LLLT preceded placement of 
calcium hydroxide. After 6 months, the RSR was 100% 
for FC group, 60% for CH group, 80% and 87.5% for 
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LLLT and LLLt +Ch group respectively. At 12 months, 
FC remained same whereas CH group reduced to 50% 
and other two were 80% and 78.6% respectively (28). 
Contradictory to the above mentioned studies two studies 
showed that LASER was better than conventional mate-
rial used for pulpotomy and only one among those stu-
dies showed statistically significant results. Liu JF et al. 
in 2006 compared Nd YAG LASER with formocresol for 
pulpotomy in deciduous molars. This was a long follow 
up study and the 68 teeth that were included in LASER 
group and 69 teeth in formocresol group were followed 
up from 6 – 68 months revealead that the success rate of 
Nd YAG LASER both clinically and radiographically 
were significantly higher than that of formocresol pulpo-
tomy.(29) Another similar study by Elliot et al. comparing 
CO2 LASER and FC pulpotomy on healthy non carious 
primary canines which  statistically insignificant differen-
ce among two groups (30). Liu JF et al. stated that this 
could be because study done by Elliot et al. included non 
carious teeth with smaller sample size (n=15) and a shor-
ter follow period of 3 months (versus 68 months) (29).
The second study was a recent study conducted by Joshi 
et al. in 2017, on 40 teeth (2 in each child) that required 
pulpotomy. The teeth were randomly allocated to either 
diode LASER or formocresol group. All cases were fo-
llowed up at 3, 6, 12 months. Although radiographically 
LASER fared much better than formocresol, the results 
among two groups were statistically insignificant. Failu-
res in the formocresol group was because only the clot 
separated the eugenol from the vital tissue, hence direct 
contact from the sub base which is zinc oxide eugenol 
lead to its hydrolysis, releasing free eugenol. Free euge-
nol induces inflammatory tissue response.  The cause for 
failures in LASER group suggested by Joshi et al. are 
carbonization, necrosis and infiltration of inflammation 
cells, edema in pulp tissue as a sequelae of LASER irra-
diation which could have caused the pathology (31).
LASER Versus Ferric Sulfate 
P Yadav et al. in 2014 compared the effects of ferric sul-
fate, electrosurgical and diode LASER pulpotomy on 45 
human deciduous molars (n=15) at 1,3,6,9months. The 
overall CSR of FS group was 86.6%, whereas diode LA-
SER and ES group both showed 100% CSR. Radiogra-
phically, also the results were not statistically significant 
(23). A similar study comparing the same three modali-
ties in pulpotomy of primary molars was conducted by 
Garima et al. in 2015. A total of 10 teeth were allotted to 
each group and followed up till 12 months. The results 
were not statistically significant both clinically and ra-
diograhically (9). 
Ansari G et al. compared formocresol, ferric sulfate, cal-
cium enriched mixture with and without LLLT pulpo-
tomy. Formocresol showed highest clinical success rate 
at 12 months but they concluded that LLLT may give fa-
vorable outcomes due to faster pulp healing. Ferric sul-
phate had more failures the reason the authors suggest is 
the difference in mechanism of action, that is formocre-
sol causes fixation whereas ferric sulphate can only help 
in hemostasis (11). Fernandez CC et al. in their study in 
2013 stated that higher number of radiographic failures 
were in FS group, as this material only caused hemos-
tasis which has higher chance of inflammation in longer 
terms unlike formocresol that causes fixation of under-
lying tissue (32). Huth et al. in 2012 assessed the long 
term (36 months) effectiveness of FC, FS, CH AND LA-
SER and found that although not statistically significant 
LASER was as good as placing formocresol (33).  
From the above studies mentioned in this study, it is 
evident that LASERS fare as good a pulpotomy medi-
cament as the gold standard formocresol and ferric sul-
phate and although it requires trained operator skill. The 
advantages of LASERS while working on children are 
reduced chair side time, painless procedure and that high 
speed airotors are not required.
Conclusions
Although the results of this study when comparing LA-
SER v/s formocresol and LASER v/s ferric sulphate, 
both the clinical and radiographical follow up at 6 and 
12 months, shows that the difference is not statistically 
significant, the studies included carried high risk of bias.
Clinical relevance
• Pulpotomy technique is a time tested and is the most 
preferred procedure in primary teeth with deep carious 
lesions (with probable pulp exposure) amongst pediatric 
dentists.
• The results of this study show that the success rates of 
LASER pulpotomy versus pulpotomy with other medi-
caments are very similar and difference among the two 
are not statistically significant, showing that  LASERS 
serve as an equally good alternative to other conventio-
nal pulpotomy medicaments escpecially formocresol 
which is considered as the gold standard for pulpotomy. 
LASER is also a safer option than formocresol pulpo-
tomy, taking into consideration the reported cytotoxic 
and mutagenic properties of formocresol.
• This evidence based data would benefit all pediatric 
dentists and general dental practitioners in choosing an 
appropriate technique for pulpotomy.
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